UV-Vis spectroscopy coupled with firefly algorithm-enhanced artificial neural networks for the determination of propranolol, rosuvastatin, and valsartan in ternary mixtures.

Journal: Scientific reports
PMID:

Abstract

In the present study, a simple, rapid and cost-effective analytical method was developed for the simultaneous determination of three commonly prescribed cardiovascular drugs: propranolol, rosuvastatin and valsartan. The method employed artificial neural networks (ANN) to model the relation between the UV absorption spectra of the drugs and their concentrations. An experimental design of 25 samples was employed as a calibration set, and a central composite design of 20 samples was used as a validation set. The firefly algorithm (FA) was evaluated as a variable selection procedure to optimize the developed ANN models resulting in simpler models with improved predictive performance as evident by lower relative root mean square error of prediction (RRMSEP) values compared to the full spectrum ANN models. Validation of the developed FA-ANN models demonstrated excellent accuracy, precision and selectivity for the quantification of the target analytes as per international conference on harmonisation (ICH) guidelines. Additionally, the greenness, analytical practicality and sustainability of the developed models were assessed using the analytical greenness (AGREE), blue applicability grade index (BAGI) and the red-green-blue (RGB) tools, confirming their environmentally friendly, practical and sustainable nature. This research shed the light on the potential of ANN coupled with UV fingerprinting for the rapid and simultaneous determination of critical cardiovascular drugs posing a significant impact on pharmaceutical quality control and patient monitoring.

Authors

  • Ahmed Serag
    AI Innovation Lab, Weill Cornell Medicine-Qatar, Doha, Qatar.
  • Maram H Abduljabbar
    Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
  • Yusuf S Althobaiti
    Addiction and Neuroscience Research Unit, Taif University, Taif 21944, Saudi Arabia.
  • Farooq M Almutairi
    Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, University of Hafr AlBatin, 39524, Hafr AlBatin, Saudi Arabia.
  • Shaker T Alsharif
    Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Rami M Alzhrani
    Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
  • Marwa F Ahmed
    Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
  • Atiah H Almalki
    Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.